Home   Bookmark and Share

 Print Friendly and PDF

Statin Drug Scandal:
Cholesterol-lowering Drug Researchers Start Backtracking;


By Health Impact

February 19, 2015 "ICH" - "HIN" - Dr. MaryAnne Demasi’s documentary on the criminal activity of the pharmaceutical industry regarding cholesterol-lowering statin drugs sent shock waves through the mainstream media in Australia at the end of 2013. Published in two parts on the popular news show The Catalyst, the pharmaceutical industry complained loudly after the first show, and requested the network not air the second episode, “Heart of the Matter Part 2 – Cholesterol Drug War.”

ABC Australia aired it anyway, but the pharmaceutical influence was apparently too strong, as they later announced that the network would remove the videos from their website because “they breached its impartiality standards.” All copies found on YouTube were also removed.

Dr. Michael Eades has published them on his Vimeo channel, however, and you can watch them below. If you know anyone currently being prescribed statin drugs to lower their cholesterol, this information could save their lives.

Heart of the Matter – Part 1

 

Heart of the Matter Part 2 – Cholesterol Drug War

Click for Spanish, German, Dutch, Danish, French, translation- Note- Translation may take a moment to load.

What's your response? -  Scroll down to add / read comments 

Email Newsletter icon, E-mail Newsletter icon, Email List icon, E-mail List icon Sign up for our FREE Daily Email Newsletter

For Email Marketing you can trust

  Support Information Clearing House

Monthly Subscription To Information Clearing House
   

 

 

 

 

 

 

 

 

 
 Please read our  Comment Policy before posting -
It is unacceptable to slander, smear or engage in personal attacks on authors of articles posted on ICH.
Those engaging in that behavior will be banned from the comment section.
 
 

 

 

 

In accordance with Title 17 U.S.C. Section 107, this material is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. Information Clearing House has no affiliation whatsoever with the originator of this article nor is Information ClearingHouse endorsed or sponsored by the originator.)

Privacy Statement